Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2021 | Story Xolisa Mnukwa

The University of the Free State (UFS) Arts and Culture office invites all Kovsie students to enjoy the soothing sounds of music and poetry performed by students from all three UFS campuses during the Student Affairs Arts Week from 22 to 29 October 2021. 

For a full Arts Week experience, visit https://www.ufs.ac.za/studentlifeartsweek where a new video will be activated daily for an exciting week-long festival.

Together with the Arts Week, a COVID-19 Vaccination Drive will take place physically on the UFS Bloemfontein Campus and on virtual platforms. The drive will host medical experts to discuss and address the concerns that students have about vaccination. 

Click here for more information on the Student Affairs Vaccination Drive.

The university is developing a COVID-19 Regulations and Mandatory Vaccination Policy to ensure a safe environment for all UFS staff and students upon their physical return to campus in 2022. 

All students are therefore encouraged to make the responsible choice to keep themselves and others safe by educating themselves through the vaccination drive.

The Student Affairs Arts Week comes after the Campus Principal of the UFS South Campus and team leader of Institutional Health and Wellness for staff and students, Dr Maria Madiope, expressed concern about how COVID-19 cursed humanity. She previously stated that both student and staff morale has been challenged and affected immensely, and she encouraged the Arts and Culture office to use the arts to boost morale and give hope. 

Mr Temba Hlasho, UFS Executive Director of Student Affairs, also expressed concern about the level of student engagement and how music and song, particularly choral music, are well known for its therapeutic and healing abilities for people when tackling various life challenges.

The Bloemfontein Choir is set to pay tribute to all students, staff, family, and UFS loved ones who have been lost since the beginning of the pandemic. 

May the music and poetry give you hope for the approaching final year-end exams and the festive season. 
 
For more information on Arts Week, contact Lucy Sehloho at sehloholp@ufs.ac.za

News Archive

UFS takes a leading role in nuclear medicine and technology
2011-12-06

 
Photo: Dr Glen Taylor

The University of the Free State (UFS) continues to play an active role in the field of Nuclear Medicine and the use of nuclear technology in the biosciences. Dr Glen Taylor, Director of Research Commercialisation and Business Development at the UFS, was recently elected chairperson of the board for the Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI).

The UFS is currently one of three centres of excellence in the country identified by the Nuclear Energy Corporation South African (Necsa) to roll out the capacity development programme and increase technology coming from nuclear medicine and technology.
NTeMBI is a national technology platform that is managed by Necsa and supported by the Department of Science and Technology (DST). It functions as a high-level Research, Development and Innovation (RD&I) initiative that will implement new strategic initiatives relating to research and development on nuclear technologies in medicine and the biosciences on a local, regional and international level. 
 
One of the roles Dr Taylor will perform as Chairperson of the board of NTeMBI, is to enhance the exposure of nuclear technology in medicine and the biosciences. Dr Taylor says the aim is to increase the skills base in South Africa. “I realise it is one of the scare skills in the country.” 
 
The UFS already received a significant amount of funding from the grant of R4 million per annum made available from the Department of Science and Technology (DST) to implement NTeMBI projects.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept